Abstract
A novel regimen incorporating the concomitant administration of fludarabine and alemtuzumab for the treatment of refractory adult acute lymphoblastic leukaemia: a report of three cases
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have